511PAURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS). (25th November 2018) - Zhou, C; Wang, M; Cheng, Y; Chen, Y; Zhao, Y; Shi, Y-K; Ahn, M-J; Lu, Y; Shi, M; Han, J-Y; Kim, S-W; Zhang, H-L; et al.